Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population

JAMA

Volumn 291, Issue 4, 2004, Pages 460-469

  Jacquemont, Sébastien ^a   Hagerman, Randi J ^a,b   Leehey, Maureen A ^c   Hall, Deborah A ^c   Levine, Richard A ^e   Brunberg, James A ^f   Zhang, Lin ^b   Jardini, Tristan ^a   Gane, Louise W ^a   Harris, Susan W ^a   Herman, Kristin ^a   Grigsby, James ^d   Greco, Claudia M ^f   Berry Kravis, Elizabeth ^g   Tassone, Flora ^f   Hagerman, Paul J ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e SAN DIEGO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALLELE; AMNESIA; ARTICLE; ATAXIA; AUTONOMIC DYSFUNCTION; BRAIN DYSFUNCTION; CEREBELLAR ATAXIA; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FRAGILE X MENTAL RETARDATION 1 GENE; FRAGILE X SYNDROME; GENE; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; PARKINSONISM; PENETRANCE; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREMOR;

EID: 9144252520     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.4.460     Document Type: Article

References (55)

1. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene-and implications for the population genetics of the fragile X syndrome Am J Hum Genet. 1995;57:1006-1018.
2. Dombrowski C, Levesque S, Morel ML, Rouillard P, Morgan K, Rousseau F. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet. 2002;11:371-378.
3. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905-914.
4. Tassone F, Hagerman RJ, Ikle DN, et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet. 1999;84:250-261.
5. Hagerman RJ, Hagerman PJ, eds. Fragile X Syndrome: Diagnosis, Treatment, and Research. 3rd ed. Baltimore, Md: Johns Hopkins University Press; 2002.
6. Dorn MB, Mazzocco MM, Hagerman RJ. Behavioral and psychiatric disorders in adult male carriers of fragile X. J Am Acad Child Adolesc Psychiatry. 1994;33:256-264.
7. Reiss AL, Freund L, Abrams MT, Boehm C, Kazazian H. Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet. 1993;52:884-894.
8. Franke P, Leboyer M, Gansicke M, et al. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res. 1998;80:113-127.
9. Sobesky WE, Taylor AK, Pennington BF, et al. Molecular/clinical correlations in females with fragile X. Am J Med Genet. 1996;64:340-345.
10. Loesch DZ, Huggins RM, Bui QM, Epstein JL, Taylor AK, Hagerman RJ. Effect of the deficits of fragile X mental retardation protein on cognitive status of fragile X males and females assessed by robust pedigree analysis. J Dev Behav Pediatr. 2002;23:416-423.
11. Riddle JE, Cheema A, Sobesky WE, et al. Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard. 1998;102:590-601.
12. Schwartz CE, Dean J, Howard-Peebles PN, et al. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet. 1994;51:400-402.
13. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet. 1999;83:322-325.
14. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:127-130.
15. Brunberg JA, Jacquemont S, Hagerman RJ, et al. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol. 2002;23:1757-1766.
16. Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003;72:869-878.
17. Leehey MA, Munhoz RP, Lang AE, et al. The fragile X premutation presenting as essential tremor. Arch Neurol. 2003;60:117-121.
18. Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain. 2002;125:1760-1771.
19. Hagerman P, Iwahashi C, Babineau B, et al. Fragile X-associated Tremor/Ataxia Syndrome (FXTAS): a common heritable neuronal inclusion disorder [abstract]. Neurology. 2003;60:A469.
20. Willemsen R, Hoogeveen-Westerveld M, Reis S, et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet. 2003;12:949-959.
21. Macpherson J, Waghorn A, Hammans S, Jacobs P. Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum Genet. 2003;112:619-620.
22. Taylor AK, Safanda JF, Fall MZ, et al. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA. 1994;271:507-514.
23. Oberle I, Rousseau F, Heitz D, et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 1991;252:1097-1102.
24. Fu YH, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67:1047-1058.
25. Louis ED, Barnes LF, Wendt KJ, et al. Validity and test-retest reliability of a disability questionnaire for essential tremor. Mov Disord. 2000;15:516-523.
26. Fahn S, Tolosa E, Marin C. Clinical Rating Scale for Tremor. In: Jankovic JJ, Tolosa E, Scott-Connor CEH, eds. Parkinson's Disease and Movement Disorders. Baltimore-Munich: Urban & Schwarzenberg; 1998:225-234.
27. Fahn S, Elton RL, for the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information; 1987:153-164.
28. Trouillas P, Takayanagi T, Hallett M, et al, for the Ataxia Neuropharmacology Committee of the World Federation of Neurology. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci. 1997;145:205-211.
29. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
30. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health. 1996;86:726-728.
31. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani J. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125:279-284.
32. Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson's Disease Rating Scale: motor examination section. Mov Disord. 1998;13:633-636.
33. Stebbins GT, Goetz CG, Lang AE, Cubo E. Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state. Mov Disord. 1999;14:585-589.
34. Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor. Mov Disord. 1994;9:193-196.
35. Louis ED, Wendt KJ, Albert SM, Pullman SL, Yu Q, Andrews H. Validity of a performance-based test of function in essential tremor. Arch Neurol. 1999;56:841-846.
36. Zhang J, Yu KF. What's the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690-1691.
37. Louis ED, Marder K, Cote L, et al. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Arch Neurol. 1995;52:1201-1205.
38. Berry-Kravis E, Lewin F, Wuu J, et al. Tremor and ataxia in fragile X premutation carriers: blinded videotape study. Ann Neurol. 2003;53:616-623.
39. Tassone F, Orrico A, Galli L, Jacquemont S, Hagerman RJ, Hagerman PJ. Spastic paraparesis and ataxia in two sisters with the fragile X premutation. Paper presented at: 8th International Fragile X Conference; July 17-21, 2002; Chicago, Ill.
40. Hagerman R, Zhang L, Brunberg J, et al Two female cases of the fragile X premutation tremor/ataxia syndrome: cognitive, molecular, and radiological studies [abstract] Neurology. 2003;60:A331.
41. Leehey MA, Grigsby J, Rubinstein D, et al. Parkinsonism, tremor and ataxia in a female fragile X carrier [abstract]. Mov Disord. 2002;17:S351.
42. Rajput AH, Offord KP, Beard CM, Kurland LT. Essential tremor in Rochester, Minnesota: a45-year study. J Neurol Neurosurg Psychiatry. 1984;47:466-470.
43. Haerer AF, Anderson DW, Schoenberg BS. Prevalence of essential tremor: results from the Copiah County study. Arch Neurol. 1982;39:750-751.
44. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of essential tremor in the Parsi community of Bombay, India. Arch Neurol. 1988;45:907-908.
45. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology. 1985;35:841-845.
46. Tandberg E, Larsen JP, Nessler EG, Riise T, Aarli JA. The epidemiology of Parkinson's disease in the county of Rogaland, Norway. Mov Disord. 1995;10:541-549.
47. Kis B, Schrag A, Ben-Shlomo Y, et al. Novel three-stage ascertainment method: prevalence of PD and parkinsonism in South Tyrol, Italy. Neurology. 2002;58:1820-1825.
48. Schrag A, Ben-Shlomo Y, Quinn NP. Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ. 2000;321:21-22.
49. Ho SC, Woo J, Lee CM. Epidemiologic study of Parkinson's disease in Hong Kong. Neurology. 1989;39:1314-1318.
50. Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet. 1999;354:1771-1775.
51. Zhang L, Leehey M, Wheelock V, Tassone F, Hagerman R, Hagerman P. A subtype of multiple system atrophy with cerebellar ataxia (MSA-C): the fragile X-associated tremor/ataxia syndrome. Neurology. 2003;60:A470.
52. Nolin SL, Brown WT, Glicksman A, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet. 2003;72:454-464.
53. Murray A, Macpherson JN, Pound MC, et al. The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission. Hum Mol Genet. 1997;6:173-184.
54. Johnston C, Eliez S, Dyer-Friedman J, et al. Neurobehavioral phenotype in carriers of the fragile X premutation. Am J Med Genet. 2001;103:314-319.
55. de Rijk MC, Tzourio C, Breteler MM, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. J Neurol Neurosurg Psychiatry. 1997;62:10-15.